Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis.

Critical reviews in oncology/hematology - 1 Jan 2020

Jafari Pourya Arbab, Sadeghian Mohammad Hadi, Miri Hamid Heidarian, Sadeghi Ramin, Bagheri Ramin, Lavasani Sroush, Souri Saeid

Abstract excerpt

Splicing factor 3B subunit 1 (SF3B1) is a complex takes part in intron splicing of pre-mRNA and mutations within it have been reported frequently in myeloid malignancies including myelodysplastic syndromes (MDS). However, its prognostic value has been controversial. Hence, we aimed this meta-analysis to investigate the prognostic effect of SF3B1 mutations in patients with MDS. Several electronic databases were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Myelodysplastic Syndromes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphoproteins

Share to Prognosis

Share to RNA Splicing

Share to RNA Splicing Factors

Share to Survival Analysis

Source

Identifiers

PMID: 31812130
DOI: 10.1016/j.critrevonc.2019.102832

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis.PMID 31812130Read ↗

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations.Semantic proximity Read ↗

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease processSemantic proximity Read ↗

[Clinical features of SF3B1 mutation in patients with myelodysplastic syndrome with excess blasts].Semantic proximity Read ↗

Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.Semantic proximity Read ↗

[Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1].Semantic proximity Read ↗

The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic SyndromeSemantic proximity Read ↗

Clinical Characteristics and Molecular Profiling of SF3B1-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice.Semantic proximity Read ↗

Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis.Semantic proximity Read ↗

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.Semantic proximity Read ↗

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity.Semantic proximity Read ↗

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.Semantic proximity Read ↗

Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.